BEIJING, June 7, 2007 / Chemclin Biotech Company Ltd., a company specialized in diagnostics reagents and systems in China, today announced that it has completed its first private fund raising. The funding was led by WI Harper Group and Siemens Venture Capital with participation of Softbank China Venture Capital. China eCapital acted as exclusive financial advisor to Chemclin on this transaction.

"We are pleased to have preeminent venture capital firms and one of the world's leading diagnostics company support our company. It is a validation of what we are doing," said Mr. Xitang Ying, CEO of Chemclin. "The advice and support of top venture capitalists will be of great assistance as we build a global company," he added.

Irene Tanner, Managing Director of China eCapital commented, "We are pleased to have played a role in Chemclin's Series A financing. The interest in China's healthcare sector is exploding and we expect to stay very active in this market."

About Beijing Chemclin Biotech

Beijing Chemclin Biotech Co., Ltd. (Chemclin) was established in 1999, and has emerged as one of China's leading diagnostics companies with its own development, manufacturing and distribution headquartered in Beijing. Chemclin develops radioimmunoassay (RIA) kits, ELISA and chemiluminescent (CLIA) kits. The company has a well-established marketing and sales network across China with presence in 30 provinces, more than 2000 local districts and 30,000 towns. More information can be found at: www.chemclin.com.

About China eCapital

China eCapital is a leading investment bank in China. Founded in 2000 with headquarters in Beijing, it provides advisory services in private placement, mergers and acquisitions (M&A), and initial public offering (IPO). With an international background and strong local presence, China eCapital has emerged as one of the most dynamic and active players in the Chinese investment banking market. While its clients encompass a wide spectrum of industries, the firm is focused on media and entertainment, technology and internet, consumer products and services, and healthcare.